Center M. SR, Jemal, A. American Cancer Society. Global Cancer Facts & Figures. 2nd ed. Atlanta: American Cancer Society; 2011.

Chhikara BS, Parang KJCBL. Global Cancer Statistics 2022: the trends projection analysis. Chemical Biology Letters. 2023;10(1):451–451.

Kumaran GC, Jayson GC, Clamp AR. Antiangiogenic drugs in ovarian cancer. Br J Cancer. 2009;100(1):1–7. https://doi.org/10.1038/sj.bjc.6604767.

Article  CAS  PubMed  Google Scholar 

Bredel M. Anticancer drug resistance in primary human brain tumors. Brain Res Brain Res Rev. 2001;35(2):161–204. https://doi.org/10.1016/s0165-0173(01)00045-5.

Article  CAS  PubMed  Google Scholar 

Goldstein DA, Stemmer SM, Gordon N. The cost and value of cancer drugs - are new innovations outpacing our ability to pay? Israel journal of health policy research. 2016;5:40. https://doi.org/10.1186/s13584-016-0097-0.

Article  PubMed  PubMed Central  Google Scholar 

Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discovery. 2019;18(1):41–58. https://doi.org/10.1038/nrd.2018.168.

Article  CAS  PubMed  Google Scholar 

Breckenridge A, Jacob R. Overcoming the legal and regulatory barriers to drug repurposing. Nat Rev Drug Discovery. 2019;18(1):1–2. https://doi.org/10.1038/nrd.2018.92.

Article  CAS  PubMed  Google Scholar 

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140–9. https://doi.org/10.2337/dc14-2441.

Article  PubMed  Google Scholar 

Jfairma. Metformin. The Johns Hopkins Patient Guide to Diabetes. The Johns Hopkins Patient Guide to Diabetes. 2022. https://hopkinsdiabetesinfo.org/medications-for-type-2-diabetes-metformin/. Accessed on 11.06.2024.

Podhorecka M, Ibanez B, Dmoszyńska AJAiH, Medicine E. Metformin–its potential anti-cancer and anti-aging effects. Postepy higieny i medycyny doswiadczalnej (Online). 2017;71:170–5.

Shmerling HR: Is metformin a wonder drug? Harvard Health. The Johns Hopkins Patient Guide to Diabetes. 2021. https://www.health.harvard.edu/blog/is-metformin-a-wonder-drug-202109222605. Accessed 29.01.2024.

The Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2012;35(4):731–7. https://doi.org/10.2337/dc11-1299.

Article  CAS  PubMed Central  Google Scholar 

NHS: Metformin. https://www.nhs.uk/medicines/metformin 2022. Accessed 30.01.2024.

Chae YK, Arya A, Malecek MK, Shin DS, Carneiro B, Chandra S, et al. Repurposing metformin for cancer treatment: current clinical studies. Oncotarget. 2016;7(26):40767–80. https://doi.org/10.18632/oncotarget.8194.

Article  PubMed  PubMed Central  Google Scholar 

Thompson MD, Cole DE, Jose PA, Chidiac P. G protein-coupled receptor accessory proteins and signalling: pharmacogenomic insights. Methods Mol Biol 2014:121–52.

Abdelmoneim M, Aboalela MA, Naoe Y, Matsumura S, Eissa IR, Bustos-Villalobos I, et al. The impact of metformin on tumor-infiltrated immune cells: preclinical and clinical studies. 2023;24(17):13353.

CAS  Google Scholar 

Lv Z, Guo Y. Metformin and its benefits for various diseases. 2020;11:191.

Google Scholar 

Haider R. The Future of Pharmaceuticals Industry 2024. J Pharmaceutics and Pharmacology Research.  2023;6(6). https://doi.org/10.31579/2693-7247/1432.

DepMap BJD. DepMap 22Q2 public. figshare. 2022;10:m9.

Corsello SM, Nagari RT, Spangler RD, Rossen J, Kocak M, Bryan JG, et al. Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nature cancer. 2020;1(2):235–48. https://doi.org/10.1038/s43018-019-0018-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603–7. https://doi.org/10.1038/nature11003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adamus A, Engel N, Seitz G. SGPL1(321) mutation: one main trigger for invasiveness of pediatric alveolar rhabdomyosarcoma. Cancer Gene Ther. 2020;27(7–8):571–84. https://doi.org/10.1038/s41417-019-0132-8.

Article  CAS  PubMed  Google Scholar 

Degagné E, Pandurangan A, Bandhuvula P, Kumar A, Eltanawy A, Zhang M, et al. Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. J Clin Investig. 2014;124(12):5368–84. https://doi.org/10.1172/jci74188.

Article  PubMed  PubMed Central  Google Scholar 

Gene Cards. The human gene database. May 21, 2023 https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCR6. Accessed 7 Jul 2023.

Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev. 2002;13(2):143–54. https://doi.org/10.1016/s1359-6101(01)00033-8.

Article  CAS  PubMed  Google Scholar 

Nonis D, Schmidt MHH, van de Loo S, Eich F, Dikic I, Nowock J, et al. Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cell Signal. 2008;20(10):1725–39. https://doi.org/10.1016/j.cellsig.2008.05.018.

Article  CAS  PubMed  Google Scholar 

Lin L, Li X, Pan C, Lin W, Shao R, Liu Y, et al. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance. Cell Death Dis. 2019;10(3):173. https://doi.org/10.1038/s41419-019-1362-2.

Article  PubMed  PubMed Central  Google Scholar 

Liao X, Song L, Zhang L, Wang H, Tong Q, Xu J, et al. LAMP3 regulates hepatic lipid metabolism through activating PI3K/Akt pathway. Mol Cell Endocrinol. 2018;470:160–7. https://doi.org/10.1016/j.mce.2017.10.010.

Article  CAS  PubMed  Google Scholar 

Liu S, Yue J, Du W, Han J, Zhang W. LAMP3 plays an oncogenic role in osteosarcoma cells partially by inhibiting TP53. Cell Mol Biol Lett. 2018;23:33. https://doi.org/10.1186/s11658-018-0099-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanao H, Enomoto T, Kimura T, Fujita M, Nakashima R, Ueda Y, et al. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Can Res. 2005;65(19):8640–5. https://doi.org/10.1158/0008-5472.Can-04-4112.

Article  CAS  Google Scholar 

Huang F, Ma G, Zhou X, Zhu X, Yu X, Ding F, et al. Depletion of LAMP3 enhances PKA-mediated VASP phosphorylation to suppress invasion and metastasis in esophageal squamous cell carcinoma. Cancer Lett. 2020;479:100–11. https://doi.org/10.1016/j.canlet.2020.03.014.

Article  CAS  PubMed  Google Scholar 

Song S, Shi Y, Wu W, Wu H, Chang L, Peng P, et al. Reticulon 3-mediated Chk2/p53 activation suppresses hepatocellular carcinogenesis and is blocked by hepatitis B virus. Gut. 2021;70(11):2159–71. https://doi.org/10.1136/gutjnl-2020-321386.

Article  CAS  PubMed  Google Scholar 

Horibe H, Kato K, Oguri M, Yoshida T, Fujimaki T, Kawamiya T, et al. Association of a polymorphism of BTN2A1 with hypertension in Japanese individuals. Am J Hypertens. 2011;24(8):924–9. https://doi.org/10.1038/ajh.2011.74.

Article  CAS  PubMed  Google Scholar 

Rigau M, Ostrouska S, Fulford TS, Johnson DN, Woods K, Ruan Z, et al. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells. Science. 2020;367(6478). https://doi.org/10.1126/science.aay5516.

Incorvaia L, Rinaldi G, Badalamenti G, Cucinella A, Brando C, Madonia G, et al. Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay. Therapeutic advances in medical oncology. 2023;15:17588359231151844. https://doi.org/10.1177/17588359231151845.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koo CY, Muir KW, Lam EW. FOXM1: From cancer initiation to progression and treatment. Biochem Biophys Acta. 2012;1819(1):28–37. https://doi.org/10.1016/j.bbagrm.2011.09.004.

Article  CAS  PubMed  Google Scholar 

Zhang B, Liu LL, Mao X, Zhang DH. Effects of metformin on FOXM1 expression and on the biological behavior of acute leukemia cell lines. Mol Med Rep. 2014;10(6):3193–8. https://doi.org/10.3892/mmr.2014.2629.

Article  CAS